922: A Randomized Prospective Phase III Trial of Difluoromethylornithine (DFMO) vs Placebo (P) in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer
Year: 2005
Type: conference-abstract
Source: The Journal of Urology
Authors: Edward M. Messing, KyungMann Kim, George Wilding, Francis Sharkey, Howard Parnes, Melissa Schultz, Daniel Kim, Daniel Saltzstein, Paul Carbone
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4233375924